Stability of lipid emulsions for drug delivery

Advanced Drug Delivery Reviews

Volumn 20, Issue 2-3, 1996, Pages 131-145

  Washington, C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLOIDS; DRUG INTERACTIONS; DRUG PRODUCTS; DRUG THERAPY; ELECTROLYTES; EMULSIONS; IONIC DRUGS; STABILITY;

COACERVATION; DRUG DELIVERY; EMOPAMIL; IONIZED DRUGS; LIPID EMULSIONS; LIPOPHILIC DRUGS; PHOSPHOLIPIDS; STABILITY MEASUREMENT; SURFACE ACTIVE DRUGS; TRIGLYCERIDE LIPID EMULSIONS;

LIPIDS;

ALTRETAMINE; AMPHOTERICIN B; BISANTRENE; CLARITHROMYCIN; CYCLOSPORIN A; DIAZEPAM; ELECTROLYTE; EMOPAMIL; FORSKOLIN; INTRALIPID; LIPID EMULSION; MITOMYCIN C; NITROSOUREA DERIVATIVE; PACLITAXEL; PENCLOMEDINE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROSTAGLANDIN A1; PROSTAGLANDIN E1; SODIUM CHLORIDE; SURFACTANT; UBIDECARENONE; UNINDEXED DRUG;

DRUG ADMINISTRATION; DRUG FORMULATION; DRUG STABILITY; FLOCCULATION; IONIZATION; LIPOPHILICITY; PHARMACEUTICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; TECHNIQUE; THEORY;

EID: 0030602783     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00116-O     Document Type: Review

References (56)

1. [1] Huang, D.X., Wu, Z.H. and Wu, Z.G. (1992) The all-in-one nutrient solution in patenteral nutrition. Clin. Nutrition. 11, 39-44.
2. [2] Bock, T.K., Lucks, J.S., Kleinebudde, P., Muller, R.H. and Muller, B.W. (1994) High-pressure homogenization of parenteral fat emulsions - influence of process parameters on emulsion quality. Eur. J. Pharmaceut. Biopharmaceut. 40, 157-160.
3. [3] Davis, S.S., Washington, C., West, P., Illum, L., Liversidge, G., Sternson L. and Kirsh, R. (1987) Lipid emulsions as drug delivery systems. Ann. NY Acad. Sci. 507, 75-88.
4. [4] Driscoll, D.F., Bhargava, H.N., Li, L., Zaim, R.H., Babayan, V.K. and Bistrian, B.R. (1995) Physicochemical stability of total nutrient admixtures. Am. J. Hosp. Pharm. 52, 623-634.
5. [5] Mehta, R.C., Head, L.F., Hazrati, A.M., Parr, M., Rapp R.P. and Deluca, P.P. (1992) Fat emulsion particle-size distribution in total nutrient admixtures. Am. J. Hosp. Pharm. 49, 2749-2755.
6. [6] Washington, C. and Davis, S.S. (1988) The production of parenteral-feeding emulsions by microfluidizer. Int. J. Pharmaceut. 44, 169-176.
7. [7] Washington, C. (1990) The stability of intravenous fat emulsions in total parenteral-nutrition mixtures. Int. J. Pharmaceut. 66, 1-21.
8. [8] Washington, C. (1992) The electrokinetic properties of phospholipid stabilized fat emulsions .6. Zeta potentials of Intralipid 20% in TPN mixtures. Int. J. Pharmaceut. 87, 167-174.
9. [9] Westesen, K. and Wehler, T. (1993) Particle-size determination of a submicron-sized emulsion. Colloids and Surfaces A - Physicochemical and Engineering Aspects 78, 125-132.
10. [10] Westesen, K. and Wehler, T. (1993) Characterization of a submicron-sized oil-in-water emulsion. Colloids and Surfaces A - Physicochemical and Engineering Aspects 78, 115-123.
11. [11] Sasaki, H., Takakura, Y., Hashida, M., Kimura, T. and Sezaki, H. (1984) Antitumour activity of lipophilic prodrugs of mitomycin C entrapped in liposome or O/W emulsion. J. Pharmacodynam. 7, 120-130.
12. [12] Carr, M. (1984) Status of Fluosol-DA 20%. J. Am. Med. Assoc. 251, 2928-2928.
13. [13] Riess, J.G. (1992) Fluorocarbon emulsions as injectable oxygen carriers - recent progress and prospects. Revue Francaise de Transfusion et de Hemobiologie 35, 391-406.
14. [14] Spence, R.K., Norcross, E.D., Costabile, J., McCoy, S., Cernaianu, A.C., Alexander, J.B., Pello, J., Atabek, U. and Camishion, R.C. (1994) Perfluorocarbons as blood substitutes - early years - experience with fluosol DA-20-percent in the 1980s. Artificial Cells Blood Substitutes and Immobilization Biotechnology 22, 955-963.
15. [15] Washington, C., Chawla, A., Christy, N. and Davis, S.S. (1989) The electrokinetic properties of phospholipid-stabilized fat emulsions. Int. J. Pharmaceut. 54, 191-197.
16. [16] Washington, C. (1990) The electrokinetic properties of phospholipid-stabilized fat emulsions .2. droplet mobility in mixed electrolytes. Int. J. Pharmaceut. 58, 13-17.
17. [17] Washington, C. (1990) The electrokinetic properties of phospholipid-stabilized fat emulsions - .3. interdroplet potentials and stability ratios in monovalent electrolytes. Int. J. Pharmaceut. 64, 67-73.
18. [18] Washington, C., Athersuch, A. and Kynoch, D.J. (1990) The electrokinetic properties of phospholipid stabilized fat emulsions .4. the effect of glucose and of pH. Int. J. Pharmaceut. 64, 217-222.
19. [19] Washington, C., Connolly, M.A., Manning, R. and Skerratt, M.C.L. (1991) The electrokinetic properties of phospholipid stabilized fat emulsions .5. the effect of amino-acids on emulsion stability. Int. J. Pharmaceut. 77, 57-63.
20. [20] Cevc, G. and Marsh, D. (1984) Phospholipid Bilayers, Physical Principles and Models, J. Wiley, New York.
21. [21] Rubino, J.T. (1990) The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions. 1. Kinetic assessment of emulsion stability. J. Parenteral Sci. Technol. 44, 210-215.
22. [22] Shaw, D.J. (1980) Introduction to Colloid and Surface Chemistry, Butterworths, London.
23. [23] Napper, D.H. (1983) Polymeric Stabilization of Colloidal Dispersions, Academic Press, London.
24. [24] Gamon, B.L., Virden, J.W. and Berg, J.G. (1989) The aggregation kinetics of an electrostatically stabilized dipalmitoyl phosphatidylcholine system. J. Coll. Int. Sci. 132, 125-137.
25. [25] Riess, J.G. and LeBlanc, M. (1988) Preparation of perfluorochemical emulsions for biomedical use: principles, materials and methods. Blood Substitutes, Ellis Horwood, Chichester, pp. 94-129.
26. [26] Deryaguin, B.V. (1940) Repulsive forces between charged colloidal particles and the theory of slow coagulation and stability of lyophobic sols. Trans. Faraday Soc. 36, 203-215.
27. [27] Verwey, E.J.W. and Overbeek, J.T.G. (1948) Theory of Stability of Lyophobic Colloids, Elsevier, Amsterdam.
28. [28] Washington, C., Ferguson, J.A. and Irwin, S.E. (1993) Computational prediction of stability of lipid emulsions in total nutrient admixtures. J. Pharm. Sci. 82, 808-812.
29. [29] Macdonald, P.M. and Seelig, J. (1987) Calcium binding to mixed PG-PC bilayers as studied by deuterium nuclear magnetic resonance. Biochemistry. 26, 1231-1240.
30. [30] Hansrani, P.K. (1980) Ph.D Thesis, Nottingham, UK.
31. [31] Allen, T. (1990) Particle Size Measurement, Chapman and Hall, London.
32. [32] Washington, C. (1990) Particle Size Analysis in Pharmaceutics and Other Industries, Ellis Horwood, Chichester.
33. [33] Washington, C. and Sizer, T. (1992) Stability of TPN mixtures compounded from Lipofundin-s and Amino-plex amino-acid solutions - comparison of laser diffraction and coulter-counter droplet size analysis. Int. J. Pharmaceut. 83, 227-231.
34. [34] Lostritto, R.T., Goei, L. and Silvestri, S.L. (1987) Theoretical considerations of drug release from submicron oil in water emulsions. J. Parenteral. Sci. Technol. 41, 214-224.
35. [35] Silvestri, S., Wu, L.L. and Bowser, B. (1992) Release of polyionizable compounds from submicrometer oil-in-water emulsions. J. Pharm. Sci. 81, 413-418.
36. [36] Hofmann, H.P., Raschack, M. and Unger, L. (1989) S-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. Drug Res. 39, 304-308.
37. [37] Forster, D., Washington, C. and Davis, S.S. (1988) Toxicity of solubilized and colloidal amphotericin-B formulations to human erythrocytes. J. Pharm. Pharmacol. 40, 325-328.
38. [38] Shoji, Y., Mizushima, Y., Yanagawa, A., Shiba, T. and Takei, H. (1986) Enhancement of anti-inflammatory effect of biphenylacetic acid by its incorporation into lipid microspheres. J. Pharm. Pharmacol. 38, 118-121.
39. [39] Desai, N.R., Shinal, E.C., Ganesan, M. and Carpentier, E.A. (1989) Emulsion compositions for administration of sparingly soluble ionizable hydrophobic drugs. U.S patent 4 816 247, American Cyanamid Co.
40. [40] Lovell, M.W., Johnson, H.W., Hui, H.W., Cannon, J.B., Gupta, P.K. and Hsu, CC. (1994) Less painful emulsion formulations for intravenous administration of clarithromycin. Int. J. Pharmaceut. 109, 45-57.
41. [41] Santos-Malaghaes, N.S., Cave, G., Seiller, M. and Benita, S. (1991) The stability and in vitro release kinetics of a clofibride emulsion. Int. J. Pharmaceut. 76, 225-237.
42. [42] Kimura, A., Yarnaguchi, H., Watanabe, K., Hayashi, M. and Awazu, S. (1986) Factors affecting the tissue distribution of coenzyme Q10 intravenously administered in an emulsion to rats: emulsifying agents and lipoprotein lipase activity. J. Pharm. Pharmacol. 38, 659-662.
43. [43] Yanagawa, A., Iwayama, T., Saotome, T., Shoji, J., Takano, K., Oka, H. and Nakagawa, T. (1989) Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres. J. Microencapsulation 6, 161-164.
44. [44] Mizushima, Y., Hamano, T. and Yokoyama, K. (1982) Use of a lipid emulsion as a novel carrier for corticosteroids. J. Pharm. Pharmacol. 34, 49-50.
45. [45] Von Dardel, O., Mebius, C., Mossberg, T. and Svensson, B. (1983) Fat emulsion as a vehicle for diazepam. A study of 9492 patients. Br. J. Anaesthesia 55, 41-47.
46. [46] Glen, J.B. and Hunter, S.C. (1984) Pharmacology of an emulsion formulation of ICI 35 868 (2,6 di-isopropylphenol). Br. J. Anaesthesia 56, 617-625.
47. [47] Yamamura, K., Nakao, M., Yano, K., Miyamoto, K. and Yotsuyanagi, T. (1991) Stability of forskolin in lipid emulsions and oil-water partition coefficients. Chem. Pharm. Bull. 39, 1032-1034.
48. [48] Gordon, I.L., Kar, R., Opfell, R.W. and Wile, A.G. (1987) Pharmacokinetics of hexamethylmelamine in Intralipid following hepatic regional administration in rabbits. Cancer Res. 47, 5070-5073.
49. [49] Lundberg, B. (1994) The solubilization of lipophilic derivatives of podophyllotoxins in submicron sized lipid emulsions and their cytotoxic activity against cancer-cells in culture. Int. J. Pharmaceut. 109, 73-81.
50. [50] Davignon, J.P., Yang, K.W., Wood, H.B. and Cradock, J.C. (1973) Formulation of three nitrosoureas for intravenous use. Cancer Chemother. Rep. 4, 7-11.
51. [51] Prankerd, R.J., Frank, S.G. and Stella, V. (1988) Preliminary development and evaluation of a parenteral formulation of penclomedine (NSC 338720; 3,5-dichloro-2,4-dimethoxy-6-trichloromethylpyridine): a novel, practically water insoluble cytotoxic agent. J. Parent. Sci. Technol. 42, 76-81.
52. [52] Paborji, M., Riley, C. and Stella, V. (1988) A novel use of Intralipid for the parenteral delivery of perilla ketone (NSC 348407), an investigational cytotoxic drug with a high affinity for plastic. Int. J. Pharmaceut. 42, 243-249.
53. [53] Hogskilde, S., Wagner, J., Carl, P. and Bredgaard Sorensen, M. (1987) Anaesthetic properties of pregnanolone emulsion. Anaesthesia 42, 1051-1056.
54. [54] Mizushima, Y. (1991) Lipo-Prostaglandin preparations. Prostaglandins, Leukotrienes and Essential Fatty Acids 42, 1-6.
55. 1, a new lipid-encapsulated preparation of prostaglandin E1: Placebo and prostaglandin E1-controlled controlled multicentre trials in patients with diabetic neuropathy and leg ulcers. Prostaglandins 46, 453-468.
56. [56] Wheeler, J.J., Wong, K.F., Ansell, S.M., Masin, D. and Bally, M.B. (1994) Polyethylene-glycol modified phospholipids stabilize emulsions prepared from triacylglycerol. J. Pharm. Sci. 83, 1558-1564.